
Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics shares (APLT) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Therapeutics employs 26 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Applied Therapeutics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – APLT. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Applied Therapeutics stock price (NASDAQ: APLT)
Use our graph to track the performance of APLT stocks over time.Applied Therapeutics shares at a glance
Latest market close | $1.14 |
---|---|
52-week range | $0.50 - $3.25 |
50-day moving average | $0.88 |
200-day moving average | $1.17 |
Wall St. target price | $15.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-4.00 |
Buy Applied Therapeutics stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Applied Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Applied Therapeutics price performance over time
Historical closes compared with the close of $1.14 from 2023-01-26
1 week (2023-01-20) | 10.68% |
---|---|
1 month (2022-12-27) | 47.10% |
3 months (2022-10-27) | 54.05% |
6 months (2022-07-27) | 11.76% |
1 year (2022-01-23) | N/A |
---|---|
2 years (2021-01-27) | -94.41% |
3 years (2020-01-27) | 50.32 |
5 years (2018-01-23) | N/A |
Applied Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -64.98% |
Return on equity TTM | -197.73% |
Profit margin | 0% |
Book value | $0.20 |
Market capitalisation | $57.2 million |
TTM: trailing 12 months
Applied Therapeutics share dividends
We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.
Applied Therapeutics share price volatility
Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $0.5 up to $3.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 1.7512. This would suggest that Applied Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Applied Therapeutics overview
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Applied Therapeutics in the news
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
Frequently asked questions
What percentage of Applied Therapeutics is owned by insiders or institutions?Currently 16.557% of Applied Therapeutics shares are held by insiders and 56.766% by institutions. How many people work for Applied Therapeutics?
Latest data suggests 26 work at Applied Therapeutics. When does the fiscal year end for Applied Therapeutics?
Applied Therapeutics's fiscal year ends in December. Where is Applied Therapeutics based?
Applied Therapeutics's address is: 545 Fifth Avenue, New York, NY, United States, 10017 What is Applied Therapeutics's ISIN number?
Applied Therapeutics's international securities identification number is: US03828A1016 What is Applied Therapeutics's CUSIP number?
Applied Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03828A101
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert